PLoS ONE (Jan 2007)

A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion.

  • Kirsten Moll,
  • Arnaud Chêne,
  • Ulf Ribacke,
  • Osamu Kaneko,
  • Sandra Nilsson,
  • Gerhard Winter,
  • Malin Haeggström,
  • Weiqing Pan,
  • Klavs Berzins,
  • Mats Wahlgren,
  • Qijun Chen

DOI
https://doi.org/10.1371/journal.pone.0000477
Journal volume & issue
Vol. 2, no. 5
p. e477

Abstract

Read online

Plasmodium falciparum malaria is brought about by the asexual stages of the parasite residing in human red blood cells (RBC). Contact between the erythrocyte surface and the merozoite is the first step for successful invasion and proliferation of the parasite. A number of different pathways utilised by the parasite to adhere and invade the host RBC have been characterized, but the complete biology of this process remains elusive. We here report the identification of an open reading frame (ORF) representing a hitherto unknown second exon of the Pf332 gene that encodes a cysteine-rich polypeptide with a high degree of similarity to the Duffy-binding-like (DBL) domain of the erythrocyte-binding-ligand (EBL) family. The sequence of this DBL-domain is conserved and expressed in all parasite clones/strains investigated. In addition, the expression level of Pf332 correlates with proliferation efficiency of the parasites in vitro. Antibodies raised against the DBL-domain are able to reduce the invasion efficiency of different parasite clones/strains. Analysis of the DBL-domain revealed its ability to bind to uninfected human RBC, and moreover demonstrated association with the iRBC surface. Thus, Pf332 is a molecule with a potential role to support merozoite invasion. Due to the high level of conservation in sequence, the novel DBL-domain of Pf332 is of possible importance for development of novel anti-malaria drugs and vaccines.